# FDA Inspection 1313566 - SOFIE Co. dba SOFIE - April 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/9f97f7aa-21b4-490d-9d7d-a4ffd9f3575a
Source feed: FDA_Inspections

> FDA Inspection 1313566 for SOFIE Co. dba SOFIE on April 21, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313566
- Company Name: SOFIE Co. dba SOFIE
- Inspection Date: 2026-04-21
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1076429 - 2019-01-15](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/626cbb81-7f76-4192-b370-00ee7bd5a150)
- [FDA Inspection 970671 - 2016-05-27](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/4b48a8f6-4267-4127-98cb-1e8e79824399)
- [FDA Inspection 854064 - 2013-10-22](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/335c0781-70cc-4f6f-b2e7-86cff4847f52)

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/3b677367-baec-43c5-8387-5939b730d8b7

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9